VaxDesign
About Us
Mission
Management
Scientific Advisory Board
Board of Directors
MIMIC® Technology
MIMIC® System Overview
Blood Collection and Processing
Peripheral Tissue Equivalent Module
Lymphoid Tissue Equivalent Module
Functional Assays and Disease Models
MIMIC Applications
Applications Overview
Vaccine and Adjuvant Immunogenicity
Immunotoxicity Predictions
Biologic Drug Immunogenicity
Vaccine Effectiveness: Clinical Trial in a Test Tube™
MIMIC Benefits
Benefits Overview
Vaccine Assessment
Immunotoxicity
Biologic Drug Immunogenicity
Customers and Collaborators
Home
News
Jobs
Donors Program
Contact Us
Case Studies
Clinical Trial in a Test Tube™ for Influenza Vaccines
Effect of Immunosuppressants and Immune Stimulants: MIMIC® System Reproduces In Vivo Results
Evaluation of Cross-Reactivity of Influenza Vaccine
Frozen Donor Cells Compared to Fresh Donor Cells
Hepatitis B Vaccine
Immune Suppression by Dexamethasone in MIMIC® System
Lymphoid Tissue Equivalent Module Versus PBMC Assay
MIMIC® Responses to OKT3 versus Avastin®
MIMIC® System Detects Immune Response to Nanoparticles
Peripheral Tissue Equivalent Module Compared to PBMC Assay
Reliability and Reproducibility with Automated MIMIC® Assays
Tetanus Vaccine
Trivalent Inactivated Influenza Vaccine (Fluzone®)
Yellow Fever Vaccine
Case Studies
Clinical Trial in a Test Tube™ for Influenza Vaccines
Effect of Immunosuppressants and Immune Stimulants: MIMIC® System Reproduces In Vivo Results
Evaluation of Cross-Reactivity of Influenza Vaccine
Frozen Donor Cells Compared to Fresh Donor Cells
Hepatitis B Vaccine
Immune Suppression by Dexamethasone in MIMIC® System
Lymphoid Tissue Equivalent Module Versus PBMC Assay
MIMIC® Responses to OKT3 versus Avastin®
MIMIC® System Detects Immune Response to Nanoparticles
Peripheral Tissue Equivalent Module Compared to PBMC Assay
Reliability and Reproducibility with Automated MIMIC® Assays
Tetanus Vaccine
Trivalent Inactivated Influenza Vaccine (Fluzone®)
Yellow Fever Vaccine